{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["182(3)"],"submitter":["Gunter SJ"],"journal":["JAMA internal medicine"],"pagination":["342-345"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8767485"],"repository":["biostudies-literature"],"pubmed_title":["Medicaid Spending on Drugs Marketed Without US Food and Drug Administration Approval in 2020."],"pmcid":["PMC8767485"],"pubmed_authors":["Rome BN","Gunter SJ","Kesselheim AS"],"additional_accession":[]},"is_claimable":false,"name":"Medicaid Spending on Drugs Marketed Without US Food and Drug Administration Approval in 2020.","description":null,"dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Mar","modification":"2025-04-26T09:58:48.157Z","creation":"2025-04-06T13:10:20.905Z"},"accession":"S-EPMC8767485","cross_references":{"pubmed":["35040875"],"doi":["10.1001/jamainternmed.2021.7614"]}}